Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Integrin Alpha V Market Growth (Status and Outlook) 2022-2028

  • LP 4929213
  • 87 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Integrin Alpha V will have significant change from previous year. According to our (LP Information) latest study, the global Integrin Alpha V market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Integrin Alpha V market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Integrin Alpha V market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Integrin Alpha V market, reaching US$ million by the year 2028. As for the Europe Integrin Alpha V landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Integrin Alpha V players cover Biogen Inc, BioMAS Ltd, Factor Therapeutics Ltd, and MedImmune LLC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Integrin Alpha V market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

MK-0429

C-16Y

264-RAD

AC-301

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Metabolic Disorders

Ophthalmology

Respiratory

Infectious Disease

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Biogen Inc

BioMAS Ltd

Factor Therapeutics Ltd

MedImmune LLC

Merck & Co Inc

Merck KGaA

Morphic Therapeutic Inc

SciFluor Life Sciences LLC

Vascular Pharmaceuticals Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Integrin Alpha V Market Size 2017-2028

2.1.2 Integrin Alpha V Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Integrin Alpha V Segment by Type

2.2.1 MK-0429

2.2.2 C-16Y

2.2.3 264-RAD

2.2.4 AC-301

2.2.5 Others

2.3 Integrin Alpha V Market Size by Type

2.3.1 Integrin Alpha V Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Integrin Alpha V Market Size Market Share by Type (2017-2022)

2.4 Integrin Alpha V Segment by Application

2.4.1 Metabolic Disorders

2.4.2 Ophthalmology

2.4.3 Respiratory

2.4.4 Infectious Disease

2.4.5 Others

2.5 Integrin Alpha V Market Size by Application

2.5.1 Integrin Alpha V Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Integrin Alpha V Market Size Market Share by Application (2017-2022)

3 Integrin Alpha V Market Size by Player

3.1 Integrin Alpha V Market Size Market Share by Players

3.1.1 Global Integrin Alpha V Revenue by Players (2020-2022)

3.1.2 Global Integrin Alpha V Revenue Market Share by Players (2020-2022)

3.2 Global Integrin Alpha V Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Integrin Alpha V by Regions

4.1 Integrin Alpha V Market Size by Regions (2017-2022)

4.2 Americas Integrin Alpha V Market Size Growth (2017-2022)

4.3 APAC Integrin Alpha V Market Size Growth (2017-2022)

4.4 Europe Integrin Alpha V Market Size Growth (2017-2022)

4.5 Middle East & Africa Integrin Alpha V Market Size Growth (2017-2022)

5 Americas

5.1 Americas Integrin Alpha V Market Size by Country (2017-2022)

5.2 Americas Integrin Alpha V Market Size by Type (2017-2022)

5.3 Americas Integrin Alpha V Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Integrin Alpha V Market Size by Region (2017-2022)

6.2 APAC Integrin Alpha V Market Size by Type (2017-2022)

6.3 APAC Integrin Alpha V Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Integrin Alpha V by Country (2017-2022)

7.2 Europe Integrin Alpha V Market Size by Type (2017-2022)

7.3 Europe Integrin Alpha V Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Integrin Alpha V by Region (2017-2022)

8.2 Middle East & Africa Integrin Alpha V Market Size by Type (2017-2022)

8.3 Middle East & Africa Integrin Alpha V Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Integrin Alpha V Market Forecast

10.1 Global Integrin Alpha V Forecast by Regions (2023-2028)

10.1.1 Global Integrin Alpha V Forecast by Regions (2023-2028)

10.1.2 Americas Integrin Alpha V Forecast

10.1.3 APAC Integrin Alpha V Forecast

10.1.4 Europe Integrin Alpha V Forecast

10.1.5 Middle East & Africa Integrin Alpha V Forecast

10.2 Americas Integrin Alpha V Forecast by Country (2023-2028)

10.2.1 United States Integrin Alpha V Market Forecast

10.2.2 Canada Integrin Alpha V Market Forecast

10.2.3 Mexico Integrin Alpha V Market Forecast

10.2.4 Brazil Integrin Alpha V Market Forecast

10.3 APAC Integrin Alpha V Forecast by Region (2023-2028)

10.3.1 China Integrin Alpha V Market Forecast

10.3.2 Japan Integrin Alpha V Market Forecast

10.3.3 Korea Integrin Alpha V Market Forecast

10.3.4 Southeast Asia Integrin Alpha V Market Forecast

10.3.5 India Integrin Alpha V Market Forecast

10.3.6 Australia Integrin Alpha V Market Forecast

10.4 Europe Integrin Alpha V Forecast by Country (2023-2028)

10.4.1 Germany Integrin Alpha V Market Forecast

10.4.2 France Integrin Alpha V Market Forecast

10.4.3 UK Integrin Alpha V Market Forecast

10.4.4 Italy Integrin Alpha V Market Forecast

10.4.5 Russia Integrin Alpha V Market Forecast

10.5 Middle East & Africa Integrin Alpha V Forecast by Region (2023-2028)

10.5.1 Egypt Integrin Alpha V Market Forecast

10.5.2 South Africa Integrin Alpha V Market Forecast

10.5.3 Israel Integrin Alpha V Market Forecast

10.5.4 Turkey Integrin Alpha V Market Forecast

10.5.5 GCC Countries Integrin Alpha V Market Forecast

10.6 Global Integrin Alpha V Forecast by Type (2023-2028)

10.7 Global Integrin Alpha V Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Biogen Inc

11.1.1 Biogen Inc Company Information

11.1.2 Biogen Inc Integrin Alpha V Product Offered

11.1.3 Biogen Inc Integrin Alpha V Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Biogen Inc Main Business Overview

11.1.5 Biogen Inc Latest Developments

11.2 BioMAS Ltd

11.2.1 BioMAS Ltd Company Information

11.2.2 BioMAS Ltd Integrin Alpha V Product Offered

11.2.3 BioMAS Ltd Integrin Alpha V Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 BioMAS Ltd Main Business Overview

11.2.5 BioMAS Ltd Latest Developments

11.3 Factor Therapeutics Ltd

11.3.1 Factor Therapeutics Ltd Company Information

11.3.2 Factor Therapeutics Ltd Integrin Alpha V Product Offered

11.3.3 Factor Therapeutics Ltd Integrin Alpha V Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Factor Therapeutics Ltd Main Business Overview

11.3.5 Factor Therapeutics Ltd Latest Developments

11.4 MedImmune LLC

11.4.1 MedImmune LLC Company Information

11.4.2 MedImmune LLC Integrin Alpha V Product Offered

11.4.3 MedImmune LLC Integrin Alpha V Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 MedImmune LLC Main Business Overview

11.4.5 MedImmune LLC Latest Developments

11.5 Merck & Co Inc

11.5.1 Merck & Co Inc Company Information

11.5.2 Merck & Co Inc Integrin Alpha V Product Offered

11.5.3 Merck & Co Inc Integrin Alpha V Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Merck & Co Inc Main Business Overview

11.5.5 Merck & Co Inc Latest Developments

11.6 Merck KGaA

11.6.1 Merck KGaA Company Information

11.6.2 Merck KGaA Integrin Alpha V Product Offered

11.6.3 Merck KGaA Integrin Alpha V Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Merck KGaA Main Business Overview

11.6.5 Merck KGaA Latest Developments

11.7 Morphic Therapeutic Inc

11.7.1 Morphic Therapeutic Inc Company Information

11.7.2 Morphic Therapeutic Inc Integrin Alpha V Product Offered

11.7.3 Morphic Therapeutic Inc Integrin Alpha V Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Morphic Therapeutic Inc Main Business Overview

11.7.5 Morphic Therapeutic Inc Latest Developments

11.8 SciFluor Life Sciences LLC

11.8.1 SciFluor Life Sciences LLC Company Information

11.8.2 SciFluor Life Sciences LLC Integrin Alpha V Product Offered

11.8.3 SciFluor Life Sciences LLC Integrin Alpha V Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 SciFluor Life Sciences LLC Main Business Overview

11.8.5 SciFluor Life Sciences LLC Latest Developments

11.9 Vascular Pharmaceuticals Inc

11.9.1 Vascular Pharmaceuticals Inc Company Information

11.9.2 Vascular Pharmaceuticals Inc Integrin Alpha V Product Offered

11.9.3 Vascular Pharmaceuticals Inc Integrin Alpha V Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Vascular Pharmaceuticals Inc Main Business Overview

11.9.5 Vascular Pharmaceuticals Inc Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Integrin Alpha V Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of MK-0429

Table 3. Major Players of C-16Y

Table 4. Major Players of 264-RAD

Table 5. Major Players of AC-301

Table 6. Major Players of Others

Table 7. Integrin Alpha V Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Integrin Alpha V Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Integrin Alpha V Market Size Market Share by Type (2017-2022)

Table 10. Integrin Alpha V Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Integrin Alpha V Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Integrin Alpha V Market Size Market Share by Application (2017-2022)

Table 13. Global Integrin Alpha V Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Integrin Alpha V Revenue Market Share by Player (2020-2022)

Table 15. Integrin Alpha V Key Players Head office and Products Offered

Table 16. Integrin Alpha V Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Integrin Alpha V Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Integrin Alpha V Market Size Market Share by Regions (2017-2022)

Table 21. Americas Integrin Alpha V Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Integrin Alpha V Market Size Market Share by Country (2017-2022)

Table 23. Americas Integrin Alpha V Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Integrin Alpha V Market Size Market Share by Type (2017-2022)

Table 25. Americas Integrin Alpha V Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Integrin Alpha V Market Size Market Share by Application (2017-2022)

Table 27. APAC Integrin Alpha V Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Integrin Alpha V Market Size Market Share by Region (2017-2022)

Table 29. APAC Integrin Alpha V Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Integrin Alpha V Market Size Market Share by Type (2017-2022)

Table 31. APAC Integrin Alpha V Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Integrin Alpha V Market Size Market Share by Application (2017-2022)

Table 33. Europe Integrin Alpha V Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Integrin Alpha V Market Size Market Share by Country (2017-2022)

Table 35. Europe Integrin Alpha V Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Integrin Alpha V Market Size Market Share by Type (2017-2022)

Table 37. Europe Integrin Alpha V Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Integrin Alpha V Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Integrin Alpha V Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Integrin Alpha V Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Integrin Alpha V Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Integrin Alpha V Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Integrin Alpha V Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Integrin Alpha V Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Integrin Alpha V

Table 46. Key Market Challenges & Risks of Integrin Alpha V

Table 47. Key Industry Trends of Integrin Alpha V

Table 48. Global Integrin Alpha V Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Integrin Alpha V Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Integrin Alpha V Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Integrin Alpha V Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Integrin Alpha V Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Integrin Alpha V Market Size Market Share Forecast by Application (2023-2028)

Table 54. Biogen Inc Details, Company Type, Integrin Alpha V Area Served and Its Competitors

Table 55. Biogen Inc Integrin Alpha V Product Offered

Table 56. Biogen Inc Integrin Alpha V Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Biogen Inc Main Business

Table 58. Biogen Inc Latest Developments

Table 59. BioMAS Ltd Details, Company Type, Integrin Alpha V Area Served and Its Competitors

Table 60. BioMAS Ltd Integrin Alpha V Product Offered

Table 61. BioMAS Ltd Main Business

Table 62. BioMAS Ltd Integrin Alpha V Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. BioMAS Ltd Latest Developments

Table 64. Factor Therapeutics Ltd Details, Company Type, Integrin Alpha V Area Served and Its Competitors

Table 65. Factor Therapeutics Ltd Integrin Alpha V Product Offered

Table 66. Factor Therapeutics Ltd Main Business

Table 67. Factor Therapeutics Ltd Integrin Alpha V Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Factor Therapeutics Ltd Latest Developments

Table 69. MedImmune LLC Details, Company Type, Integrin Alpha V Area Served and Its Competitors

Table 70. MedImmune LLC Integrin Alpha V Product Offered

Table 71. MedImmune LLC Main Business

Table 72. MedImmune LLC Integrin Alpha V Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. MedImmune LLC Latest Developments

Table 74. Merck & Co Inc Details, Company Type, Integrin Alpha V Area Served and Its Competitors

Table 75. Merck & Co Inc Integrin Alpha V Product Offered

Table 76. Merck & Co Inc Main Business

Table 77. Merck & Co Inc Integrin Alpha V Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Merck & Co Inc Latest Developments

Table 79. Merck KGaA Details, Company Type, Integrin Alpha V Area Served and Its Competitors

Table 80. Merck KGaA Integrin Alpha V Product Offered

Table 81. Merck KGaA Main Business

Table 82. Merck KGaA Integrin Alpha V Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Merck KGaA Latest Developments

Table 84. Morphic Therapeutic Inc Details, Company Type, Integrin Alpha V Area Served and Its Competitors

Table 85. Morphic Therapeutic Inc Integrin Alpha V Product Offered

Table 86. Morphic Therapeutic Inc Main Business

Table 87. Morphic Therapeutic Inc Integrin Alpha V Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Morphic Therapeutic Inc Latest Developments

Table 89. SciFluor Life Sciences LLC Details, Company Type, Integrin Alpha V Area Served and Its Competitors

Table 90. SciFluor Life Sciences LLC Integrin Alpha V Product Offered

Table 91. SciFluor Life Sciences LLC Main Business

Table 92. SciFluor Life Sciences LLC Integrin Alpha V Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. SciFluor Life Sciences LLC Latest Developments

Table 94. Vascular Pharmaceuticals Inc Details, Company Type, Integrin Alpha V Area Served and Its Competitors

Table 95. Vascular Pharmaceuticals Inc Integrin Alpha V Product Offered

Table 96. Vascular Pharmaceuticals Inc Main Business

Table 97. Vascular Pharmaceuticals Inc Integrin Alpha V Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Vascular Pharmaceuticals Inc Latest Developments

List of Figures

Figure 1. Integrin Alpha V Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Integrin Alpha V Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Integrin Alpha V Market Size Market Share by Type in 2021

Figure 7. Integrin Alpha V in Metabolic Disorders

Figure 8. Global Integrin Alpha V Market: Metabolic Disorders (2017-2022) & ($ Millions)

Figure 9. Integrin Alpha V in Ophthalmology

Figure 10. Global Integrin Alpha V Market: Ophthalmology (2017-2022) & ($ Millions)

Figure 11. Integrin Alpha V in Respiratory

Figure 12. Global Integrin Alpha V Market: Respiratory (2017-2022) & ($ Millions)

Figure 13. Integrin Alpha V in Infectious Disease

Figure 14. Global Integrin Alpha V Market: Infectious Disease (2017-2022) & ($ Millions)

Figure 15. Integrin Alpha V in Others

Figure 16. Global Integrin Alpha V Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Integrin Alpha V Market Size Market Share by Application in 2021

Figure 18. Global Integrin Alpha V Revenue Market Share by Player in 2021

Figure 19. Global Integrin Alpha V Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Integrin Alpha V Market Size 2017-2022 ($ Millions)

Figure 21. APAC Integrin Alpha V Market Size 2017-2022 ($ Millions)

Figure 22. Europe Integrin Alpha V Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Integrin Alpha V Market Size 2017-2022 ($ Millions)

Figure 24. Americas Integrin Alpha V Value Market Share by Country in 2021

Figure 25. Americas Integrin Alpha V Consumption Market Share by Type in 2021

Figure 26. Americas Integrin Alpha V Market Size Market Share by Application in 2021

Figure 27. United States Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Integrin Alpha V Market Size Market Share by Region in 2021

Figure 32. APAC Integrin Alpha V Market Size Market Share by Application in 2021

Figure 33. China Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Integrin Alpha V Market Size Market Share by Country in 2021

Figure 40. Europe Integrin Alpha V Market Size Market Share by Type in 2021

Figure 41. Europe Integrin Alpha V Market Size Market Share by Application in 2021

Figure 42. Germany Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Integrin Alpha V Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Integrin Alpha V Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Integrin Alpha V Market Size Market Share by Application in 2021

Figure 50. Egypt Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Integrin Alpha V Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 56. APAC Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 57. Europe Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 59. United States Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 60. Canada Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 63. China Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 64. Japan Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 65. Korea Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 67. India Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 68. Australia Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 69. Germany Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 70. France Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 71. UK Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 72. Italy Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 73. Russia Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 74. Spain Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 77. Israel Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Integrin Alpha V Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Integrin Alpha V Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390